Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sclerotherapy vs N-butyl-2-cyanoacrylate for bleeding esophageal varices
NCT03388125Phase 3Unknown
- Start
- Jan 2016
- Primary completion
- Aug 2017
- Modality
- Injectable Hydrogels, Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of N-butyl-2-cyanoacrylate, ethanolamine oleate in esophageal varices. Status: unknown.
02
Drugs
N-butyl-2-cyanoacrylateethanolamine oleate
03
Conditions
esophageal varices
Beyond the preview
Go deeper on NCT03388125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03388125.